Douglas Losordo

Douglas Losordo

Chief Medical Officer, Cadrenal Therapeutics; Board of Directors, Longeveron
Verified email at cadrenal.com
Cited by 41275
ronald engerman, R. L. Engerman, R. Engerman

ronald engerman, RL Engerman, R. Engerman

Professor, University of Wisconsin
Verified email at wisc.edu
Cited by 8654
Christopher A. Mitchell

Christopher A. Mitchell

Professor of Tissue Regeneration
Verified email at ulster.ac.uk
Cited by 7976
Fatima Sehba

Fatima Sehba

Mount Sinai School of Medicine
Verified email at mssm.edu
Cited by 3599
Rebecca R Foster

Rebecca R Foster

University of Bristol
Verified email at bristol.ac.uk
Cited by 3406
Otto Alexander Sanchez

Otto Alexander Sanchez

University of Minnesota
Verified email at umn.edu
Cited by 2217
Julie K. Freed

Julie K. Freed

Associate Professor, Medical College of Wisconsin
Verified email at mcw.edu
Cited by 1240
Mohammad Afzal Khan

Mohammad Afzal Khan

Assistant professor, University of Maryland
Verified email at som.umaryland.edu
Cited by 1134
Tony Lim

Tony Lim

Department of Pharmacology, University of Cambridge
Verified email at cam.ac.uk
Cited by 792
Dino Premilovac

Dino Premilovac

University of Tasmania
Verified email at utas.edu.au
Cited by 619
1 - 10